Overview
Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS
Status:
Terminated
Terminated
Trial end date:
2006-01-01
2006-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To evaluate the effects of VSL#3 on symptoms associated with diarrhea predominant IBSPhase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Beth Israel Deaconess Medical Center
Criteria
Inclusion Criteria:- IBS diarrhea
Exclusion Criteria:
- < 18 years of age
- Pregnancy/breast feeding
- concomitant medications to reduce bowel function